Management Team:

Board of Directors:

Clinical Advisory Board:

Susan Gilmour, Ph.D. Professor, Lankenau Institute for Medical Research


Susan Gilmour is a Professor at the Lankenau Institute for Medical Research in Wynnewood, PA, and in the Dept. of Pathology, Anatomy, and Cell Biology at the Thomas Jefferson University in Philadelphia, PA.  Dr. Gilmour is an internationally respected leader in the field of polyamines and carcinogenesis.  Over the past 22 years, she has maintained a strong and continuous record of publications and NIH funding in cancer research.  She pioneered the generation and use of transgenic animal models to study mechanisms responsible for the tumor-promoting role of polyamines in the development of skin cancer.  She was co-awarded a patent for the K6/ODC mouse model, and was one of the founding members of the ODC Mouse Group, Inc. that used the K6/ODC mouse model as a rapid and sensitive in vivo screen for carcinogens.  Dr. Gilmour has been the principal investigator in key preclinical animal studies to demonstrate the anti-tumor efficacy of polyamine targeted therapy in a variety of aggressive animal tumor models.  She has served as a standing member of NIH and DOD study sections and is an invited speaker for many international conferences.


After earning her B.A. in Biology from the University of Virginia, Dr. Gilmour earned her Ph.D. in Toxicology from Rutgers University/University of Medicine and Dentistry and continued postdoctoral training in molecular carcinogenesis at the Wistar Institute before joining the scientific staff at the Lankenau Institute for Medical Research.


--Close Window--

Corporate Counsel:

  • LinkedIn Classic
  • Facebook Classic
  • Twitter Social Icon

​Follow us at @mbftherapeutics

© 2020 MBF Therapeutics.   Advanced Immunotherapeutics for Life Sciences.  All rights reserved.